MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME

被引：0
|
作者：
BERG, E
STENBJERG, S
ALBRECHTSEN, OK
机构：
来源：
JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY | 1979年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 235
页数：7
相关论文
共 50 条
  • [31] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Waele, JJ
    Cauwenberghe, S
    Hoste, E
    Benoit, D
    Colardyn, F
    INTENSIVE CARE MEDICINE, 2003, 29 (02) : 325 - 328
  • [32] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Jan J. De Waele
    Sebastiaan Van Cauwenberghe
    Eric Hoste
    Dominique Benoit
    Francis Colardyn
    Intensive Care Medicine, 2003, 29 : 664 - 664
  • [33] The use of the activated clotting time for monitoring heparin therapy in critically ill patients
    Jan J. De Waele
    Sebastiaan Van Cauwenberghe
    Eric Hoste
    Dominique Benoit
    Francis Colardyn
    Intensive Care Medicine, 2003, 29 : 325 - 328
  • [34] Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass
    Welsby I.J.
    McDonnell E.
    El-Moalem H.
    Stafford-Smith M.
    Toffaletti J.G.
    Journal of Clinical Monitoring and Computing, 2002, 17 (05) : 287 - 292
  • [35] BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME
    REINER, JS
    COYNE, KS
    LUNDERGAN, CF
    ROSS, AM
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01): : 49 - 52
  • [36] Heparin monitoring in the ICU: The value of the activated clotting time
    De Waele, JJHC
    Van Cauwenberghe, S
    Hoste, E
    Oeyen, S
    Benoit, D
    Depuydt, P
    Colardyn, F
    INTENSIVE CARE MEDICINE, 2002, 28 : S179 - S179
  • [37] HEPARIN MONITORING DURING CORONARY INTERVENTION - ACTIVATED CLOTTING TIME VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME
    NATH, FC
    MULLER, DWM
    ROSENSCHEIN, U
    ELLIS, SG
    TOPOL, EJ
    CANADIAN JOURNAL OF CARDIOLOGY, 1993, 9 (09) : 797 - 801
  • [38] ACTIVATED COAGULATION TIME METHOD FOR CONTROL OF HEPARIN IS RELIABLE DURING CARDIOPULMONARY BYPASS
    COHEN, JA
    ANESTHESIOLOGY, 1984, 60 (02) : 121 - 124
  • [39] USE OF ACTIVATED CLOTTING TIME FOR MONITORING ANTICOAGULATION DURING CARDIOPULMONARY BYPASS IN INFANTS AND CHILDREN WITH CONGENITAL HEART-DISEASE
    LITWIN, SB
    MITRA, SK
    VONCOLDITZ, R
    VONCOLDITZ, J
    HAMILTON, LB
    MCMANUS, T
    JUMEAN, HG
    LAZERSON, J
    CARDIOVASCULAR DISEASES, 1981, 8 (03): : 364 - 371
  • [40] COMPARATIVE-ANALYSIS OF THE ACTIVATED CLOTTING TIME, HEPARIN CONCENTRATION, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN MONITORING HEPARIN-THERAPY
    HOLLENSEAD, SC
    DIXON, J
    TRIPLETT, DA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 89 (03) : 429 - 429
12345